Mizuho Lowers Acadia Healthcare (NASDAQ:ACHC) Price Target to $70.00

Acadia Healthcare (NASDAQ:ACHC) had its price target cut by Mizuho from $84.00 to $70.00 in a research note released on Friday morning, Benzinga reports. They currently have a neutral rating on the stock.

A number of other brokerages have also issued reports on ACHC. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a sell rating to a hold rating and set a $70.00 target price for the company in a research report on Thursday, April 25th. Bank of America dropped their target price on shares of Acadia Healthcare from $105.00 to $90.00 and set a buy rating on the stock in a report on Thursday, May 2nd. Cantor Fitzgerald restated a neutral rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, March 5th. Barclays cut their price objective on Acadia Healthcare from $100.00 to $91.00 and set an overweight rating for the company in a research report on Thursday, May 2nd. Finally, Royal Bank of Canada reaffirmed an outperform rating and set a $94.00 price objective on shares of Acadia Healthcare in a research note on Monday, March 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Moderate Buy and a consensus target price of $88.89.

Acadia Healthcare Trading Up 2.5 %

Acadia Healthcare stock opened at $67.78 on Friday. The firm has a 50-day moving average price of $76.42 and a two-hundred day moving average price of $77.45. Acadia Healthcare has a 52-week low of $64.74 and a 52-week high of $87.77. The firm has a market capitalization of $6.29 billion, a price-to-earnings ratio of -484.11, a PEG ratio of 1.96 and a beta of 1.31. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. During the same period in the prior year, the company posted $0.75 EPS. The business’s revenue for the quarter was up 9.1% compared to the same quarter last year. Sell-side analysts expect that Acadia Healthcare will post 3.56 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 2.00% of the stock is currently owned by corporate insiders.

Institutional Trading of Acadia Healthcare

Several large investors have recently modified their holdings of the company. Vanguard Group Inc. raised its holdings in Acadia Healthcare by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after acquiring an additional 30,296 shares in the last quarter. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock valued at $529,991,000 after buying an additional 152,783 shares in the last quarter. William Blair Investment Management LLC lifted its holdings in shares of Acadia Healthcare by 0.3% during the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock worth $215,072,000 after acquiring an additional 10,062 shares during the period. Bank of New York Mellon Corp increased its stake in Acadia Healthcare by 1.1% in the third quarter. Bank of New York Mellon Corp now owns 1,258,459 shares of the company’s stock valued at $88,482,000 after acquiring an additional 13,765 shares during the period. Finally, Avidity Partners Management LP raised its position in Acadia Healthcare by 61.8% in the fourth quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after purchasing an additional 441,692 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.